Kasia Kozlowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kasia Kozlowska has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
Stephen Scher
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
26 shared publicationsHelene Helgeland
Department of Child and Adolescent Mental Health in Hospitals, Oslo University Hospital, Oslo, Norway
19 shared publications- Stephen Scher
Harvard University
15 shared publications Catherine Chudleigh
Department of Psychological Medicine The Children's Hospital at Westmead, Australia, University of Sydney Medical School Sydney New South Wales Australia
6 shared publications- David Lewis Perez
Mass General Brigham Departments of Neurology and Psychiatry, Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
6 shared publications Blanche Savage
Department of Psychological Medicine The Children's Hospital at Westmead, Australia, University of Sydney Medical School Sydney New South Wales Australia
5 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by SAGE Publications in Human Systems: Therapy, Culture and Attachments
From pickle juice to chemosensation: A discussion on the interoceptive/homeostatic reset system for interventions in dissociation and trauma-related dysregulation
This article explores a variety of chemosensory strategies – pungent foods, ammonia salts, and essential oils – as potentially useful interventions for clinical states of dissociative shutdown (including functional/dissociative seizures); re-experiencing symptoms of posttraumatic stress disorder; and other states involving changes in arousal and a loss of balance in the neural pathways or networks crucial for the processing and integration of somatic, or body-based, sensations, as a result of stress-system dysregulation or trauma-related experiences. All of these states are common in clinical practice. Patients find them distressing as they interfere with normal daily function, quality of life, and capacity to manage the daily challenges of life. Based on the current literature we, the authors, provide an update pertaining to the current knowledge base about the neurobiology that underlies the therapeutic effects and clinical utility of these chemosensory substances. Whilst the use of chemosensory substances goes back into antiquity, our understanding of underlying neurobiological mechanisms is just beginning to emerge.
- 26 June 2026
- Published by SAGE Publications in Human Systems: Therapy, Culture and Attachments
Open AccessFrom pickle juice to chemosensation: A discussion on the interoceptive/homeostatic reset system for interventions in dissociation and trauma-related dysregulation
This article explores a variety of chemosensory strategies – pungent foods, ammonia salts, and essential oils – as potentially useful interventions for clinical states of dissociative shutdown (including functional/dissociative seizures); re-experiencing symptoms of posttraumatic stress disorder; and other states involving changes in arousal and a loss of balance in the neural pathways or networks crucial for the processing and integration of somatic, or body-based, sensations, as a result of stress-system dysregulation or trauma-related experiences. All of these states are common in clinical practice. Patients find them distressing as they interfere with normal daily function, quality of life, and capacity to manage the daily challenges of life. Based on the current literature we, the authors, provide an update pertaining to the current knowledge base about the neurobiology that underlies the therapeutic effects and clinical utility of these chemosensory substances. Whilst the use of chemosensory substances goes back into antiquity, our understanding of underlying neurobiological mechanisms is just beginning to emerge.
- Open Access
- 12 January 2026
- Published by SAGE Publications in Human Systems: Therapy, Culture and Attachments
- Vol. 6 (2) , 148-165
Pickle juice – and other pungent foods – as a grounding strategy for managing episodes of dissociative shutdown
Dissociative shutdown states occur when the individual encounters inescapable stress or trauma – or memories of inescapable stress or trauma. In the therapeutic space – occupational therapy, psychotherapy, or family therapy – working with shutdown states poses a clinical challenge. The individual’s loss of full awareness of what they are doing, or their loss of capacity to feel their body, to think, or to move or act, can bring the therapeutic process to a halt. Over the last half-century, body-oriented therapists working with the felt sense of the body, therapists working with patients presenting with complex trauma, and therapists working with patients with functional/dissociative seizures have introduced the use of grounding strategies to help patients maintain their connection with the body, self, close others, and the environment. This article explores the use of pickle juice (and other pungent foods) as a useful grounding strategy for managing dissociative shutdown states. Clinical examples are provided via vignettes. Also provided are a hypothesis and neurobiological model – the homeostatic sensory-reset hypothesis – as to why pickle juice and other pungent foods, which activate special sensory receptors in the gastrointestinal tract called transient receptor potential channels, help to disrupt and alleviate dissociation shutdown states.
- 12 January 2026
- Published by SAGE Publications in Human Systems: Therapy, Culture and Attachments
- Vol. 6 (2) , 148-165
Open AccessPickle juice – and other pungent foods – as a grounding strategy for managing episodes of dissociative shutdown
Dissociative shutdown states occur when the individual encounters inescapable stress or trauma – or memories of inescapable stress or trauma. In the therapeutic space – occupational therapy, psychotherapy, or family therapy – working with shutdown states poses a clinical challenge. The individual’s loss of full awareness of what they are doing, or their loss of capacity to feel their body, to think, or to move or act, can bring the therapeutic process to a halt. Over the last half-century, body-oriented therapists working with the felt sense of the body, therapists working with patients presenting with complex trauma, and therapists working with patients with functional/dissociative seizures have introduced the use of grounding strategies to help patients maintain their connection with the body, self, close others, and the environment. This article explores the use of pickle juice (and other pungent foods) as a useful grounding strategy for managing dissociative shutdown states. Clinical examples are provided via vignettes. Also provided are a hypothesis and neurobiological model – the homeostatic sensory-reset hypothesis – as to why pickle juice and other pungent foods, which activate special sensory receptors in the gastrointestinal tract called transient receptor potential channels, help to disrupt and alleviate dissociation shutdown states.
- Open Access
- 17 July 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1560873
The adjunct role of pharmacotherapy in multimodal treatment of paediatric functional neurological disorder
Background: Rehabilitation for children with functional neurological disorder (FND) requires a biopsychosocial intervention: physiotherapy, psychotherapy, pharmacotherapy, school attendance, and family work. This study documents the pharmacotherapeutic element and its rationale.Methods: Medication use was documented in 158 children with FND (41 boys, 117 girls, aged 8.50–17.58; mean 13.78) admitted into the Mind-Body Program.Results: On presentation, children with FND had high levels of functional impairment, school loss, and comorbid psychiatric, functional, and medical disorders. On admission, 63% (n=95) were on medications. During admission, 130 (82.3%) children had pharmacotherapy interventions: dose adjustment, initiation, or discontinuation. 88.6% (n=140) were discharged on medications. Pharmacotherapy targets included: antidepressants for anxiety/depression (n=111; 70.3%); antipsychotics for extreme anxiety/arousal (n=73; 46.2%); melatonin for sleep (n=64; 40.5%); α agonists and β blockers, for arousal, sleep initiation, and trauma-related nightmares (n=58; 36.7%); iron/vitamin supplementation (n=30; 19.0%); and medications for functional gut symptoms (n=28; 17.7%) and comorbid pain (n=20; 12.7%).Conclusions: Pharmacotherapy is used as an adjunct in paediatric FND to down-regulate the stress system, reset the circadian clock, manage pain, and treat comorbid disorders. Pharmacotherapy and its concomitant placebo effects scaffold the child to enable engagement in all components of the therapeutic process and return to healthy function.
- 17 July 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1560873
Open AccessThe adjunct role of pharmacotherapy in multimodal treatment of paediatric functional neurological disorder
Background: Rehabilitation for children with functional neurological disorder (FND) requires a biopsychosocial intervention: physiotherapy, psychotherapy, pharmacotherapy, school attendance, and family work. This study documents the pharmacotherapeutic element and its rationale.Methods: Medication use was documented in 158 children with FND (41 boys, 117 girls, aged 8.50–17.58; mean 13.78) admitted into the Mind-Body Program.Results: On presentation, children with FND had high levels of functional impairment, school loss, and comorbid psychiatric, functional, and medical disorders. On admission, 63% (n=95) were on medications. During admission, 130 (82.3%) children had pharmacotherapy interventions: dose adjustment, initiation, or discontinuation. 88.6% (n=140) were discharged on medications. Pharmacotherapy targets included: antidepressants for anxiety/depression (n=111; 70.3%); antipsychotics for extreme anxiety/arousal (n=73; 46.2%); melatonin for sleep (n=64; 40.5%); α agonists and β blockers, for arousal, sleep initiation, and trauma-related nightmares (n=58; 36.7%); iron/vitamin supplementation (n=30; 19.0%); and medications for functional gut symptoms (n=28; 17.7%) and comorbid pain (n=20; 12.7%).Conclusions: Pharmacotherapy is used as an adjunct in paediatric FND to down-regulate the stress system, reset the circadian clock, manage pain, and treat comorbid disorders. Pharmacotherapy and its concomitant placebo effects scaffold the child to enable engagement in all components of the therapeutic process and return to healthy function.
- Open Access
- 28 February 2025
- Published by Springer Nature
- p. 1-11
Introduction: Looking Back and Looking Forward
- 28 February 2025
- Published by Springer Nature
- p. 1-11
Open AccessIntroduction: Looking Back and Looking Forward
- Open Access
- 28 February 2025
- Published by Springer Nature
- p. 113-129
Informal Ethical Discourse and the Touchstone Questions
- 28 February 2025
- Published by Springer Nature
- p. 113-129
Open AccessInformal Ethical Discourse and the Touchstone Questions